BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32307014)

  • 1. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19.
    Song JC; Wang G; Zhang W; Zhang Y; Li WQ; Zhou Z;
    Mil Med Res; 2020 Apr; 7(1):19. PubMed ID: 32307014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19].
    Mei H; Hu Y
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):185-191. PubMed ID: 32133825
    [No Abstract]   [Full Text] [Related]  

  • 3. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection.
    Llau JV; Ferrandis R; Sierra P; Hidalgo F; Cassinello C; Gómez-Luque A; Quintana M; Amezaga R; Gero M; Serrano A; Marcos P
    Rev Esp Anestesiol Reanim (Engl Ed); 2020; 67(7):391-399. PubMed ID: 32591185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the relationship between coronavirus infection and coagulation function.
    Zou H; Xiong WF
    Chin Med J (Engl); 2020 Jun; 133(12):1489-1490. PubMed ID: 32209889
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of a Coagulation Disorders Unit.
    Szanto T; Helin T; Joutsi-Korhonen L; Lehtinen AE; El Beayni N; Lepäntalo A; Lassila R
    Semin Thromb Hemost; 2024 Jul; 50(5):687-694. PubMed ID: 38373723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
    Al-Samkari H; Karp Leaf RS; Dzik WH; Carlson JCT; Fogerty AE; Waheed A; Goodarzi K; Bendapudi PK; Bornikova L; Gupta S; Leaf DE; Kuter DJ; Rosovsky RP
    Blood; 2020 Jul; 136(4):489-500. PubMed ID: 32492712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unique characteristics of COVID-19 coagulopathy.
    Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M
    Crit Care; 2020 Jun; 24(1):360. PubMed ID: 32552865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and its implications for thrombosis and anticoagulation.
    Connors JM; Levy JH
    Blood; 2020 Jun; 135(23):2033-2040. PubMed ID: 32339221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum.
    Barnes GD; Burnett A; Allen A; Blumenstein M; Clark NP; Cuker A; Dager WE; Deitelzweig SB; Ellsworth S; Garcia D; Kaatz S; Minichiello T
    J Thromb Thrombolysis; 2020 Jul; 50(1):72-81. PubMed ID: 32440883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 coagulopathy vs disseminated intravascular coagulation.
    Levi M
    Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 cytokine storm: the interplay between inflammation and coagulation.
    Jose RJ; Manuel A
    Lancet Respir Med; 2020 Jun; 8(6):e46-e47. PubMed ID: 32353251
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
    Spiezia L; Boscolo A; Poletto F; Cerruti L; Tiberio I; Campello E; Navalesi P; Simioni P
    Thromb Haemost; 2020 Jun; 120(6):998-1000. PubMed ID: 32316063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulopathy of Coronavirus Disease 2019.
    Iba T; Levy JH; Levi M; Connors JM; Thachil J
    Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation Panel in Patients with SARS-CoV2 Infection (COVID-19).
    Guevara-Noriega KA; Lucar-Lopez GA; Nuñez G; Rivera-Aguasvivas L; Chauhan I
    Ann Clin Lab Sci; 2020 May; 50(3):295-298. PubMed ID: 32581015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.
    Spyropoulos AC; Levy JH; Ageno W; Connors JM; Hunt BJ; Iba T; Levi M; Samama CM; Thachil J; Giannis D; Douketis JD;
    J Thromb Haemost; 2020 Aug; 18(8):1859-1865. PubMed ID: 32459046
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 update: Covid-19-associated coagulopathy.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
    [No Abstract]   [Full Text] [Related]  

  • 19. ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
    Thachil J; Tang N; Gando S; Falanga A; Cattaneo M; Levi M; Clark C; Iba T
    J Thromb Haemost; 2020 May; 18(5):1023-1026. PubMed ID: 32338827
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulopathy in COVID-19: Manifestations and management.
    Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
    Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.